BPC-157 works on the injury site reducing local inflammation and rebuilding tissue
The main protest of PA patients surrounds not only the quality, but also the frequency of their treatment
In general, there is the cytoprotection concept: the described effects of the stable gastric pentadecapeptide BPC 157 (that has been found to be safe in ulcerative colitis trials, phase II, without a lethal dose (LD1) in the toxicology studies) were ascribed to its particular cytoprotective capabilities and pleiotropic background as an acting cytoprotective peptide that protects cells and may cure muscle disturbances in particular [11,12,13,14,24,25]
In the same way, given after, BPC 157 can ameliorate the original beneficial course after intra(per)-oral application of 96%-ethanol at the tongue, swallowed, (and then the tongue, esophagus, and duodenum presented with extensive redness, and in particular, those minor lesions in the stomach all markedly further improved)